Featured news from NHIVNA
HIV-related news from NAM
Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection
Liz Highleyman, 2015-07-29 10:10:00
People with HIV and HCV co-infection, with liver cirrhosis, who achieve sustained virological response (SVR) and experience an improvement in liver fibrosis are less likely to develop liver disease complications or die from liver-related causes – and in some cases fibrosis regression is beneficial even in the absence of a cure – according to a presentation at the Eighth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) last week in Vancouver, Canada.
A related study looked at predictors of liver fibrosis progression in people with HIV and HCV co-infection, finding that use of certain NRTI ‘backbone’ antiretroviral drugs and HIV protease inhibitors may increase the risk.
Source:1
